Clinical Trial Update: Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/Phase 2 study of tazemetostat in newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma treated with chemotherapy. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma

Drugs mentioned

• TAZVERIK (TAZEMETOSTAT)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Lymphoma, DLBCL | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING